Tom Pack and Erica Holzer to Serve on a Panel for DRI Webinar on Preemption in Drug and Medical Device Cases

Tom Pack and Erica Holzer, attorneys in Maslon's Litigation Group, will serve on a panel for a webinar presented by DRI's Young Lawyer Committee on June 20, 2019. The webinar, titled "Preemption in Drug and Medical Device Cases: An Overview and Hot Topics," will provide a brief introduction to federal preemption, aimed at new lawyers. They will also discuss how to strategically raise the preemption defense in a variety of forums and will conclude with a forecast of where federal preemption is headed, particularly given the impending changes to the FDA's 501(k) clearance program.

Tom represents businesses in product liability matters and in other complex business litigation. He helps clients navigate all stages of the litigation process throughout many forums, including federal and state courts, mediation, and arbitration. Tom has extensive experience with discovery, including eDiscovery, and has prepared successful dispositive motions in several matters. He also has experience representing a global leading medical device manufacturer in several external medical tort matters. Additionally, Tom maintains an active pro bono practice in the civil rights and immigration law fields, with an emphasis on representing LGBTQ+ asylum seekers.

Erica represents clients in complex commercial disputes primarily in the areas of tort and product liability, consumer fraud, business torts, and breach of contract actions. Erica's product liability defense work spans many industries, with particular experience in FDA-approved medical devices, representing a major medical device manufacturer in federal and state courts throughout the country. She has also developed specialized experience providing advice and compliance support to government contractors and companies on public law issues, particularly state and federal open records laws, including the Minnesota Government Data Practices Act and the federal Freedom of Information Act.

For more information or to register, go to: DRI Webinars, "Preemption in Drug and Medical Device Cases."